beta

CERC

Cerecor, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Cerecor, Inc. engages in the development and commercialization of treatments for rare pediatric and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.

Market Cap: 158 Million

Primary Exchange: NASDAQ

Website: http://www.cerecor.com

Shares Outstanding: 59.6 Million

Float: 53.1 Million

Dividend: (%)

Beta: 1.47001711059493

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Longest drawdown: 337 trading days

From: 2019-02-27 To: 2020-06-04

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud